Core A: Administrative Core

核心A：行政核心

• 批准号: 10708829
• 负责人: James Brugarolas
• 金额: $ 14.59万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2027-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10708829
• 关键词: Advocacy; Advocate; Automobile Driving; Award; Cancer Center; Cancer Patient; Cancer Research Project; Cancer Survivor; Caregivers; Caring; Clinic; Clinical; Common Neoplasm; Communication; Communities; Complex; Comprehensive Cancer Center; Core Facility; Country; County Hospitals; Development; Education; Event; Faculty; Faculty Recruitment; Fostering; Foundations; Funding; Future; Goals; Health Resources; Healthcare; Hospitals; Incidence; Institution; Interdisciplinary Study; Kidney; Leadership; Malignant Neoplasms; Medical center; Mission; Monitor; Office of Administrative Management; Organizational Objectives; Patient advocacy; Patients; Program Evaluation; Renal carcinoma; Reporting; Research; Research Personnel; Resource Allocation; Role; Services; Structure; Texas; Translating; Underrepresented Minority; Universities; anticancer research; cancer care; career; data management; equity, diversity, and inclusion; experience; innovation; multidisciplinary; patient population; programs; recruit; role model; sound; success; synergism; volunteer

Project Summary For reasons unknown, Texas has one of the highest incidence rates of kidney cancer in the US. UT Southwestern Medical Center (UTSW), together with its affiliates, the county hospital, Parkland Memorial Hospital (staffed by UTSW faculty), and Texas Health Resources, cares for 57% of all new kidney cancer patients in the Dallas-Fort Worth metroplex. At UTSW Simmons Comprehensive Cancer Center (SCCC), kidney cancer is the 5th most common tumor type. In 2013, the Kidney Cancer Program (KCP) was inaugurated. Recognized with a Leaders in Clinical Excellence Program Award and a finalist for the metroplex Innovation in Healthcare Award, the KCP has been a trailblazer. Directed by Dr. Brugarolas, and with the goal to promote collaborative, interdisciplinary research to translate discovery and technical innovation at UTSW, the KCP provides a foundation for the UTSW Kidney SPORE and serves as a vehicle for its integration within UTSW/SCCC. As the coordinating hub of the SPORE, the Administrative Core provides essential administrative services and organizational support to the SPORE as a whole. The Director of the Core, Dr. Brugarolas, will continue to provide overall direction and scientific leadership, promote multidisciplinary interactions, and oversee fiscal management and reporting. His scientific background, experience across the research continuum and administrative roles enable him to serve as an effective overall SPORE PI and Director of the Administrative Core. Dr. Kapur, Co-Leader of the KCP and previously SPORE PI successor, has been promoted to SPORE PI and Core A Co-Director. Dr. Conacci-Sorrell, an underrepresented minority and Co-Leader of the CEP, will also be joining the Administrative Core as Co- Director. An Executive Committee comprised of representatives from all Projects and Cores provides advice on SPORE strategic directions, departmental and administrative interactions, faculty recruitment, and resource allocation. A Patient Advocacy team representing the spectrum of the cancer experience (from current patients to cancer survivors and caregivers) is actively engaged in leading community and educational events, fundraising, and perhaps most inspiringly, volunteering at SCCC clinics to assist other patients. An Internal Advisory Board made up of institutional leaders serves as a sounding board, and an External Advisory Board of leaders in their fields with complementary expertise assists by evaluating progress and providing input on future directions. The KCP/SPORE benefits from a strong commitment from both UTSW and the SCCC with each committing $200,000 yearly to promote kidney cancer research, thereby extending the reach of the CEP and DRP programs, as well as $1,100,000 in recruitment funds. Core A will continue to fulfill its objectives through the following Aims. Aim 1: Partnering with the SCCC and UTSW to advance a program of excellence in kidney cancer. Aim 2: Serving and engaging the kidney cancer patient population. Aim 3: Furthering a state-of-the-art translational kidney cancer research program. Aim 4: Recruiting investigators through successful Developmental Research and Career Enhancement Programs. Aim 5: Supporting and leading national initiatives.

项目摘要 由于未知的原因，德克萨斯州是美国肾癌发病率最高的地区之一。UT西南 医疗中心（UTSW），连同其附属机构，县医院，帕克兰纪念医院（由 UTSW教师）和德克萨斯州卫生资源，照顾达拉斯堡所有新肾癌患者的57% 值得大都市。在UTSW西蒙斯综合癌症中心（SCCC），肾癌是第五大癌症。 常见肿瘤类型2013年，肾癌项目（KCP）启动。被公认为领导者 临床卓越计划奖和大都市创新医疗保健奖的决赛选手，KCP 是一个开拓者。由Brugarolas博士指导，目标是促进合作，跨学科 研究转化发现和技术创新在UTSW，KCP提供了基础， UTSW肾孢子，并作为其在UTSW/SCCC内整合的载体。作为协调中心 在战略规划办公室中，行政核心提供基本的行政服务和组织支持， 孢子作为一个整体核心主任Brugarolas博士将继续提供总体指导， 科学领导，促进多学科互动，监督财政管理和报告。他 科学背景，跨研究连续体的经验和行政角色使他能够为 作为一个有效的整体SPORE PI和行政核心主任。Kapur博士，KCP的共同领导人， 此前，他是SPORE PI的继任者，现已晋升为SPORE PI和Core A联席总监。科纳奇-索雷尔博士 一个代表性不足的少数民族和CEP的共同领导人，也将加入行政核心作为共同， 导演由所有项目和核心的代表组成的执行委员会提供以下建议： SPORE战略方向，部门和行政互动，教师招聘和资源 配置中代表癌症经历谱的患者倡导团队（来自当前患者 癌症幸存者和照顾者）积极参与领导社区和教育活动， 筹款，也许最鼓舞人心的是，在SCCC诊所做志愿者帮助其他病人。内部 由机构领导人组成的咨询委员会充当咨询委员会，外部咨询委员会 在各自领域具有互补专长的领导人的协助下，评估进展情况， 未来的方向KCP/SPORE受益于UTSW和SCCC的坚定承诺， 各承诺每年提供20万美元用于促进肾癌研究，从而扩大CEP的覆盖范围 和DRP计划，以及110万美元的招聘资金。核心A将继续通过以下方式实现其目标： 以下目标。目标1：与SCCC和UTSW合作，推进肾脏卓越计划 癌目标2：服务和参与肾癌患者群体。目标3：促进最新技术水平 转化性肾癌研究计划。目标4：通过成功的发展招募研究人员 研究和职业发展计划。目标5：支持和领导国家举措。